Description:

CALGB 90802 Registration Worksheet Form Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=879626AD-DB8C-4AF2-E040-BB89AD4364E1

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=879626AD-DB8C-4AF2-E040-BB89AD4364E1

Keywords:
Versions (4) ▾
  1. 12/18/14
  2. 1/9/15
  3. 1/9/15
  4. 9/20/21
Uploaded on:

September 20, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Kidney Cancer NCT01198158 Registration - CALGB 90802 Registration Worksheet Form - 3103555v1.0

Details

Randomized Phase III Trial Comparing Everolimus Plus Placebo Versus Everolimus Plus Bevacizumab for Advanced Renal Cell Carcinoma Progressing After Treatment with Tyrosine Kinase Inhibitors

Header Module
Protocol Administration
Patient Demographics/pre-treatment Characteristics
Gender
Race (Mark all that apply)
Ethnicity (Mark one)
Patient Demographics/pre-treatment Characteristics2
Performance Status (ECOG/Zubrod scale)
cm
Kg
m2
Method of Payment (USA only Mark one)
7 more items in the detailed view.
Patient Demographics/pre-treatment Characteristics3
Certification Of Eligibility And Protocol Design
In the opinion of the investigator, is the patient eligible?
Protocol Design
Initial Patient Consent For Specimen Use
Patient's Initial Consent given for specimen use for research on the patient's cancer
Patient's initial consent given for specimen use for genetic research relating to the study treatment
Patient's Initial Consent given for specimen kept for future use in research to learn about, prevent, or treat cancer
Patient's initial consent given for specimen(s) may be kept for use in research to learn about, prevent, or treat other health problems (for example: diabetes, Alzheimer's disease, or heart disease)
My doctor or someone from CALGB may contact me in the future to ask me to take part in more research
Calgb 580902
Was the patient registered to CALGB 580902 (a companion to CALGB 90802)
Registration Information
Back to the top of the page 

Similar models